Di Virgilio, Roberto, Pfizer Italia

• Vol 15, No 4 (2014) - Original research
  Cost‑effectiveness analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients
  Abstract  HTML  PDF